AHA Video: Price unveils GRAVITAS results
Click to play
AHA Video: Matthew J. Price, MD
GRAVITAS Principal Investigator
CHICAGO—Matthew J. Price, MD, sits down to discuss the much-anticipated results of the late-breaking GRAVITAS trial, along with the importance of platelet reactivity testing in real-life clinical practice to ensure more personalized therapy.

Price also touches upon the next steps of research, including whether phenotyping or genotyping patients who are candidates for an antiplatelet therapy is applicable.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup